C4 Therapeutics annual total assets
2019
2020
2021
2022
2023
2024
2025
C4 Therapeutics Total Assets Growth & History (CCCC)
C4 Therapeutics's total assets was $359.1M for fiscal 2025.
View full C4 Therapeutics company overviewC4 Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $359.1M | $9.5M | +2.71% |
| 2024 | 2024-12-31 | $349.6M | −$26.8M | −7.13% |
| 2023 | 2023-12-31 | $376.5M | −$54.4M | −12.62% |
| 2022 | 2022-12-31 | $430.8M | −$75.9M | −14.98% |
| 2021 | 2021-12-31 | $506.8M | $106.6M | +26.65% |
| 2020 | 2020-12-31 | $400.1M | $281.9M | +238.35% |
| 2019 | 2019-12-31 | $118.3M | — | — |
C4 Therapeutics quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $359.4M | $62.9M | +21.20% |
| Q1 2026 | 2026-03-31 | $328.9M | $9.3M | +2.92% |
| Q4 2025 | 2025-12-31 | $359.1M | $9.5M | +2.71% |
| Q3 2025 | 2025-09-30 | $265.5M | −$110.6M | −29.40% |
| Q2 2025 | 2025-06-30 | $296.5M | −$84.6M | −22.19% |
| Q1 2025 | 2025-03-31 | $319.5M | −$78.8M | −19.79% |
| Q4 2024 | 2024-12-31 | $349.6M | −$26.8M | −7.13% |
| Q3 2024 | 2024-09-30 | $376.1M | $43.0M | +12.93% |
| Q2 2024 | 2024-06-30 | $381.1M | $6.1M | +1.62% |
| Q1 2024 | 2024-03-31 | $398.4M | $2.3M | +0.59% |
| Q4 2023 | 2023-12-31 | $376.5M | −$54.4M | −12.62% |
| Q3 2023 | 2023-09-30 | $333.0M | −$128.4M | −27.83% |
| Q2 2023 | 2023-06-30 | $375.0M | −$117.5M | −23.85% |
| Q1 2023 | 2023-03-31 | $396.0M | −$119.4M | −23.17% |
| Q4 2022 | 2022-12-31 | $430.8M | −$75.9M | −14.98% |
| Q3 2022 | 2022-09-30 | $461.4M | −$46.5M | −9.15% |
| Q2 2022 | 2022-06-30 | $492.5M | −$35.9M | −6.80% |
| Q1 2022 | 2022-03-31 | $515.5M | $141.5M | +37.83% |
| Q4 2021 | 2021-12-31 | $506.8M | $106.6M | +26.65% |
| Q3 2021 | 2021-09-30 | $507.9M | $278.8M | +121.67% |
| Q2 2021 | 2021-06-30 | $528.4M | — | — |
| Q1 2021 | 2021-03-31 | $374.0M | — | — |
| Q4 2020 | 2020-12-31 | $400.1M | $281.9M | +238.35% |
| Q3 2020 | 2020-09-30 | $229.1M | — | — |
| Q4 2019 | 2019-12-31 | $118.3M | — | — |
C4 Therapeutics total assets trends
Over the last five fiscal years, C4 Therapeutics's total assets decreased from $400.1M to $359.1M, a change of −$41.1M. The latest reported quarter, Q2 2026, shows $359.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review C4 Therapeutics source filings ↗